Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 9.15
+0.23 (2.58%)
Sep 1, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Revenue
Berry Genomics Co.,Ltd had revenue of 236.55M CNY in the quarter ending June 30, 2026, with 2.99% growth. This brings the company's revenue in the last twelve months to 929.15M, down -4.59% year-over-year. In the year 2025, Berry Genomics Co.,Ltd had annual revenue of 929.82M, down -13.76%.
Revenue (ttm)
929.15M
Revenue Growth
-4.59%
P/S Ratio
3.48
Revenue / Employee
698.08K
Employees
1,331
Market Cap
3.23B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 929.82M | -148.35M | -13.76% |
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.72B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.63B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Amoy Diagnostics | 1.18B |
| Thalys Medical Technology Group | 836.23M |
| SMO ClinPlus CO.,LTD. | 824.77M |
| Guangdong Hybribio Biotech | 654.72M |